Baseline clinical characteristics | (n = 43) | |
---|---|---|
Disease duration years, median (SD) (range) | 9 (8.9) (1–29) | |
Concomitant Immunosuppressant: (n) (%) | Thiopurine/MTX | 12 (27.9%) |
Prior anti-TNF therapy: n (%) | 9 (20.9) | |
Calpro: median (range) | 800 (336–1376) | |
CRP: median (range) | 8 (1–106) | |
Concomitant Glucocorticoids: n (%) | Total | 26 (60.4) |
<20 mg per day | 6 (23%) | |
20–30 mg per day | 15 (57.2%) | |
>30 mg per day | 5 (19.2%) |